ELISHEVA BADIAN: Open Payments
NPI 1134774136 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,666 in 92 payments from 15 companies in 2025. Trend: 2023 $1,789 · 2024 $1,297 · 2025 $1,666
Food & beverage: $1,646Education: $20
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 34 | $589 |
| Janssen Biotech, Inc. | 20 | $376 |
| Madrigal Pharmaceuticals | 12 | $159 |
| PFIZER INC. | 6 | $116 |
| Ardelyx, Inc. | 4 | $85 |
| Gilead Sciences, Inc. | 3 | $59 |
| Aimmune Therapeutics, Inc. | 2 | $57 |
| Phathom Pharmaceuticals, Inc. | 2 | $44 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $40 |
| Novo Nordisk Inc | 1 | $33 |
Products named: TREMFYA, RINVOQ, REZDIFFRA, VELSIPITY, IBSRELA, SKYRIZI, CREON, MAVYRET.
Industry payments across MD — which companies pay providers there.
